A
Archus Orthopedics
Developer of a reconstructive implant to treat degenerative diseases of the lumbar spine
About Archus Orthopedics
Archus Orthopedics, founded in 2001 and headquartered in Redmond, Washington, was a medical device company focused on developing reconstructive implants for degenerative diseases of the lumbar spine. The company was the brainchild of inventor Mark Reiley, M.D. The firm's core objective was to provide an alternative to spinal fusion, a common procedure that, while stabilizing the spine, eliminates motion and can lead to adjacent-level degeneration.
The company's flagship product was the Total Facet Arthroplasty System (TFAS™), a patented spinal implant designed to treat spinal stenosis. This condition involves the narrowing of the spinal canal, which compresses spinal nerves and causes pain and neurological symptoms in the legs. The TFAS™ was a prosthetic joint that replaced degenerated facet joints, intending to restore stability and maintain motion in the spine, thus obviating the need for fusion. This approach also aimed to eliminate the need for painful bone graft harvesting from the patient's hip, a common requirement in fusion procedures. The system was designed to be used as an adjunct to procedures like laminectomy and facetectomy.
Archus Orthopedics operated in the therapeutic devices and orthopedics sector, targeting patients suffering from moderate to severe spinal stenosis. The company's business model revolved around the development and commercialization of these specialized spinal implants. A significant milestone was achieved in March 2005 when the company received CE Mark approval, allowing the TFAS™ to be marketed in the European Union. Following this, in the same year, the U.S. Food and Drug Administration (FDA) granted an Investigational Device Exemption (IDE), permitting Archus to commence a pivotal clinical trial in the United States. By 2007, the company had expanded its product line with the TFAS-LS™, designed specifically for the lumbosacral spinal level, and had successfully implanted its devices in over one hundred patients globally.
The company secured significant financial backing, raising a total of $61 million across four funding rounds from investors including Polaris Partners, InterWest Partners, MPM Capital, and Johnson & Johnson Innovation. Despite these achievements and promising clinical developments, Archus Orthopedics faced financial challenges. In September 2009, the company shut down due to a lack of capital needed to continue its large-scale clinical trials. Subsequently, in November 2009, its assets were acquired by Facet Solutions.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Nov 2009 | $0 | — | Facet Solutions | — |
| EARLY VCOther financing | Feb 2008 | $10M | $40M | GE Capital | — |
Growth signals
Latest recorded traffic for Archus Orthopedics is 390 monthly website visits. Archus Orthopedics's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Archus Orthopedics in the Redmond ecosystem
The Archus Orthopedics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
MPM BioImpact
Polaris Partners
InterWest Partners
GE Capital
Series B and later1 investor entered at this stage
Johnson & Johnson Development Corporation
Other known investors1 additional known investor
- FSFacet Solutions
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Archus Orthopedics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Archus Orthopedics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










